There are a range of cost-containment measures across the bill that will create a significant healthcare system shakeup.

Reliable power is no longer simply an operational requirement. It has become part of the economic development conversation.

Synokem Pharmaceuticals Ltd. outlines its four-decade journey, manufacturing infrastructure, research capabilities, strategic expansion and focus on pharmaceutical development as a CDMO.

Looking to invest in biotech stocks? Learn what they are, explore top options, and find out how to get started in this fast-growing, exciting industry.

The proposed rule would allow multiple manufacturing units at different locations to register as one establishment.

Software enhancements for medical device, pharmaceutical and biotechnology teams support regulatory readiness, traceability ...

With PAT, pharmaceutical manufacturers achieve real-time process control, enhancing drug quality and accelerating the ...

Patient advocates in remission from MCL and FL discuss their experiences with treatment, as well as their views on CAR-T ...

A surge in drug development and a severe shortage of laboratory primates have driven the price of research macaques in China ...

FTV Capital, a leading sector-focused growth equity investment firm, today announced that it ranked third in the 2025 HEC Paris-Dow Jones Growth Capital Performance Ranking. FTV has been named among ...

Collaboration pairs MycoTechnology's Zukora™ Honey Truffle Sweet Protein with Adorvia's proprietary Reb M stevia to support better-tasting, lower-sugar food and beverage formulations worldwide ...

Peer-Reviewed Letter to the Editor Describes Updated Long-Term Findings Consistent with Initial Trial Data Featured in NEJM Article Published in 2025 ...